Cut through the noise.
Trade on the signal.
A weekly synthesis of institutional-grade financial reports and market mechanics.
No spam. Unsubscribe anytime.
Report Archive, Page 14
12 of 188 reportsAirSculpt – A “Liposuction Chop-Shop’s” Cover-up of Patient’s Death, Sanctioned/Under-Certified Doctors, Fabricated Reviews, and Photoshopped Images Exposed
Shocking exposé reveals AirSculpt Technologies' fatal medical malpractice, patient death, fraudulent marketing, and unqualified surgeons in devastating investigative report detailing dangerous cosmetic procedures and ...
DocGo – Allegations of Fraudulent Billing Practices & Forging of Documents
DocGo Medicare fraud allegations exposed: NASDAQ DCGO faces NY investigations, whistleblower claims of test billing fraud, signature forgery, and systematic healthcare service misconduct by mobile health provider
Safety Shot Exposed: A Phony Alcohol Detox Drink Backed by a Fake Study and Peddled by Shady Cast of Characters Using Aggressive Stock Promotion
Safety Shot (NASDAQ: SHOT) stock analysis reveals impossible alcohol detox claims, management fraud risks, and potential stock collapse driven by aggressive promotions and lack of scientific evidence
Arbor Realty Trust – Slumlord Millionaires
Viceroy Research exposes Arbor Realty Trust's $7.6B multifamily loan crisis: Impossible refinancing, 0.63x debt coverage, slumlord properties, and imminent portfolio collapse under rising interest rates
FingerMotion: A Flawed Business Model Funded Via Aggressive Stock Promotion and Shareholder Dilution
Capybara Research exposes FingerMotion (NASDAQ: FNGR) as a low-margin Chinese telecom middleman burning cash, engaging in aggressive stock promotion, and facing imminent shareholder dilution through massive share issu...
Evidence Reveals Pulse Biosciences Is A Joke – It’s Years Late To The Pulsed Field Ablation Market And Its “Nanosecond” Technology Is Impractical And Not Novel – $1 Price Target
Pulse Biosciences (PLSE) faces critical challenges in cardiac ablation technology, burning $15M quarterly with minimal revenue, unproven nsPFA technology, and significant bankruptcy risks in competitive medical device...
More Problems at Knightscope – A Supplemental Report
Knightscope (KSCP) financial analysis reveals critical insolvency risks: extreme share dilution, negative margins, minimal robot revenue, auditor concerns, and potential bankruptcy threatening investor capital
Knightscope: An Unprofitable Company With a Flawed Product, High Cash Burn, and Inevitable Dilution
Knightscope (KSCP) stock analysis reveals cash-burning security robot company with failed deployments, high costs, and imminent shareholder dilution. Critical research exposes operational risks and financial instabili...
Xponential Fitness (XPOF) – “Abusive Franchisor That Is A House Of Cards”
Exposing Xponential Fitness (XPOF) fraud: CEO's questionable past, franchisee losses, manipulated metrics, potential debt crisis, and systematic financial misrepresentation in boutique fitness industry
Rego Payment Architectures has A Weak Product, Recently Added Debt And Significant Dilution – 25c 1-Year Price Target
White Diamond Research exposes Rego Payment Architectures (RPMT) with a 75% downside risk, highlighting Mazoola's failed product, mounting $20M debt, minimal revenue, and potential stock dilution in the competitive fi...
Sell Lucid – We Believe Buyout Rumor is FAKE NEWS – Came Right After Lock-up Expiration
Fuzzy Panda Research exposes Lucid Group (LCID) stock manipulation through false Saudi PIF buyout rumor, revealing negative margins, poor delivery rates, and potential market deception in electric vehicle sector
Know Labs Is An Obvious Medical Device Scam, We’re Calling: “Theranos’ Retarded Cousin”
White Diamond Research exposes Know Labs (KNW) as a potential medical device scam, revealing zero revenue, unproven glucose monitoring technology, massive share dilution, and lack of scientific validation in devastati...